Friday, July 15, 2011

iPrEx OLE to Build on News that PrEP Slows HIV Infections Significantly in Both Men Who Have Sex with Men and Heterosexual Women and Men

 via iPrEx News

The iPrEx Open-Label Extension Study (iPrEx OLE), the next phase of the first human study to report efficacy results on pre-exposure prophylaxis (PrEP) to prevent HIV infection, has begun at clinical trial sites around the world. Approximately 2,000 men and transgender women who have sex with men are expected to participate in the 72-week iPrEx OLE study. Study sites in the United States and South Africa are enrolling participants now, as other study sites finalize the regulatory approval process.

In PrEP, antiretroviral medications that are usually used to treat HIV are taken by uninfected people to reduce their risk of infection. The iPrEx study found that men and transgender women who have sex with men (MSM) who took a single daily tablet containing the HIV medications emtricitabine and tenofovir (FTC/TDF), known commercially as Truvada®, experienced an average of 44% fewer HIV infections than those who received a placebo (blank pill).

HIV infection rates in the iPrEx study dropped by 90% among those who used PrEP consistently enough to have detectable drug in the body. The HIV risk reduction benefits of PrEP were in addition to those provided by safer sex counseling, condoms, HIV testing and the detection and treatment of sexually transmitted infections. iPrEx study results were published in the New England Journal of Medicine in November, 2010.

The news of the start of iPrEx OLE follows the announcements by two other major PrEP studies, Partners PrEP and the CDC study in Botswana, known as TDF2, which demonstrated the safety and efficacy of PrEP in heterosexual women and men.

AdvertisementiPrEx OLE is a continuation of the iPrEx study that will collect additional data on PrEP efficacy, safety and adherence. All HIV-negative participants who took part in the original iPrEx study and who wish to participate will receive FTC/TDF for HIV prevention for 72 weeks through iPrEx OLE. No placebo will be used in the Open Label Extension.

"We are in a critical moment in HIV prevention research," said iPrEx Protocol Chair Robert Grant, MD, MPH of the Gladstone Institutes and the University of California at San Francisco. "iPrEx provided the first proof of an important new method of HIV prevention that can help slow the global toll of 2.6 million new HIV infections each year. Partners PrEP and the TDF2 study have now expanded that finding by demonstrating the effectiveness of PrEP in heterosexual women and men.

Developing and deploying proven HIV prevention methods -- including PrEP, microbicides, vaginal gels, clean needles, medical male circumcision, early treatment, counseling, testing, condoms and suppressive therapy for pregnant women will all be key to slowing the global epidemic."

Read more.

1 comment:

  1. For comparisons sake, what do you think we would do differently for preventing new infections if people died immediately from this disease?...


Related Posts Plugin for WordPress, Blogger...

select key words

2007 National HIV Prevention Conference 2009 National LGBTI Health Summit 2011 LGBTI Health Summit 2012 Gay Men's Health Summit 2012 International AIDS Conference abstinence only ACT Up activism advocacy Africa african-american aging issues AIDS AIDS Foundation of Chicago anal cancer anal carcinoma anal health anal sex andrew's anus athlete ball scene bareback porn barebacking bathhouses bears big bold and beautiful Bisexual Bisexual Health Summit bisexuality black gay men black msm blood ban blood donor body image bottom Brian Mustanski BUTT Center on Halsted Charles Stephens Chicago Chicago Black Gay Men's Caucus Chicago Task Force on LGBT Substance Use and Abuse Chris Bartlett chubby chaser circumcision civil rights civil union Coaching with Jake communication community organizing condoms Congress crystal meth dating dating and mating with alan irgang David Halperin David Munar depression disclosure discrimination domestic violence don't ask don't tell douche downlow Dr. James Holsinger Dr. Jesus Ramirez-Valles Dr. Rafael Diaz Dr. Ron Stall drag queen Ed Negron emotional health ENDA Eric Rofes exercise Feast of Fun Feel the love... female condom fitness Friday is for Faeries FTM gay culture gay identity gay latino gay male sex gay marriage gay men gay men of color gay men's health Gay Men's Health Summit 2010 gay pride gay rights gay rugby gay sex gay youth gender harm reduction hate crime HCV health care health care reform health insurance hepatitis C HIV HIV care HIV drugs HIV negative HIV positive HIV prevention HIV stigma HIV strategic plan HIV testing hiv vaccine HIV/AIDS homophobia homosexuality hottie hotties how are you healthy? Howard Brown Health Center HPV human rights humor hunk Illinois IML immigration International AIDS Conference international mr. leather internet intimacy IRMA Jim Pickett leather community leathersex Leon Liberman LGBT LGBT adoption LGBT culture LGBT health LGBT rights LGBT seniors LGBT youth LGBTI community LGBTI culture LGBTI health LGBTI rights LGBTI spirituality LGV LifeLube LifeLube forum LifeLube poll LifeLube subscription lifelube survey Lorenzo Herrera y Lozano love lube lubricant Lymphogranuloma Venereum masturbation mental health microbicides middle Monday Morning Perk-Up MRSA MSM music National AIDS Strategy National Gay Men's Health Summit negotiated safety nutrition One Fey's Tale oral sex Peter Pointers physical health Pistol Pete pleasure PnP podcast policy politics poppers porn post-exposure prophylaxis PrEP President Barack Obama Presidential Campaign prevention Project CRYSP prostate prostate cancer public health public sex venues queer identity racism Radical Faerie recovery rectal microbicides relationships religion research safe sex semen Senator Barack Obama sero-adaptation sero-sorting seroguessing sex sexual abuse sexual addiction sexual health sexual orientation Sister Glo Sisters of Perpetual Indulgence smoking social marketing spirituality STD stigma stonewall riots substance abuse treatment substance use suicide super-bug superinfection Susan Kingston Swiss declaration syphilis Ted Kerr Test Positive Aware Network testicle self-examination testicular cancer testing The "Work-In" The 2009 Gay Men's Health Agenda Tony Valenzuela top Trans and Intersex Association trans group blog Trans Gynecology Access Program transgender transgender day of remembrance transgendered transmen transphobia transsexual Trevor Hoppe universal health care unsafe sex vaccines video violence viral load Who's That Queer Woof Wednesday writers yoga You Tube youtube